Despite the fact that published preclinical data clearly show that an organic nitrate with HO-1 inducing properties such as PETN has less side effects [31] and even has beneficial effects on experimental hypertension [32], diabetes [34], and atherosclerosis [95], these findings still lack molecular proof in human subjects to increase the clinical importance of this concept. The gene discussed is HMOX1; the disease is atherosclerosis.